A detailed history of Harbour Investments, Inc. transactions in Geron Corp stock. As of the latest transaction made, Harbour Investments, Inc. holds 13,165 shares of GERN stock, worth $52,528. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,165
Previous 100 13065.0%
Holding current value
$52,528
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$4.17 - $4.99 $54,481 - $65,194
13,065 Added 13065.0%
13,165 $59,000
Q3 2023

Nov 15, 2023

BUY
$2.11 - $3.28 $211 - $328
100 New
100 $0
Q4 2021

Feb 16, 2022

SELL
$1.22 - $1.72 $122 - $172
-100 Closed
0 $0
Q1 2021

Aug 17, 2021

BUY
$1.52 - $2.1 $152 - $210
100 New
100 $0

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.51B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Harbour Investments, Inc. Portfolio

Follow Harbour Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investments, Inc. with notifications on news.